Abstract
A prerequisite for an optimal therapeutic effect of antimicrobial chemotherapy is not only an adequate antibiotic but also a functionally intact immune system (2,3,72). The latter requirement applies to bacteriostatic drugs as well as to bactericidal ones. A state of primary or secondary immunodeficiency may, therefore, impair the therapeutic effect of antibiotics (22,43,56). In this context, the question arose if antibiotics influence immune defense mechanisms by themselves, i.e., besides their proper antimicrobial activity, immune defense mechanisms (19). Since methods for evaluating the immune status are increasingly available, this problem has become an area of growing interest. Many antibiotics have been assayed in vitro and in vivo with regard to their influence on different immunological parameters (15,16,23–25,27,28,39). The aim of these experiments was to obtain predictive results whether an antibiotic will induce by itself, independent of its antimicrobial effect, an enhancement or depression of immune response.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
L. A. Aarden, Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors, J. Immunol. 123:2928 (1979).
D. Adam, P. Philipp and B. H. Belohradsky, Studies on the influence of host defence mechanisms on the antimicrobial effect of chemothera-peutic agents. Effect of antibiotics on phagocytosis of mouse-peritoneal-macrophages in vitro, Arztl. Forsch. 25:181 (1971).
D. Adam, F. Staber, B. H. Belohradsky and W. Marget, Effect of dihydrostreptomycin on phagocytosis of mouse-peritoneal macrophages in vitro, Infect. Immun. 5:537 (1972).
A. C. Allison, Mechanisms by which activated macrophages inhibit lymphocyte responses, Immunol. Rev. 40:3 (1978).
W. B. Anderson and I. Pastan, Altered adenylate cyclase activity: its role in growth regulation and malignant transformation of fibroblasts, Adv. Cyclic Nucleotide Res. 5:681 (1975).
F. Arenzana-Seisdedos and J. L. Virelizier, Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipo-p>olysaccharide-stimulated human monocytes, Eur. J. Immunol. 13:437 (1983).
G. Banck and A. Forsgren, Antibiotics and suppression of lymphocyte function in vitro, Antimicrob. Agents Chemother. 16:554 (1979).
R. J. Bonney and J. L. Humes, Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages, J. Leukocyte Biol. 35:1 (1984).
H. R. Bourne, L. B. Epstein and K. L. Melmon, Lymphocyte cyclic adenosine monophosphate (AMP) synthesis and inhibition of phyt©hemagglutinin-induced transformation, J. Clin. Invest. 50:10a (1971).
H. R. Bourne, L. M. Lichtenstein, K. L. Melmon, C. S. Henney, Y. Weinstein and G. M. Shearer, Modulation of inflammation and immunity by cyclic AMP, Science 184:19 (1974).
S. J. Bromberg, S. Goodwin and G. T. Peake, Receptors for prostaglandin E on human peripheral blood mononuclear cells, Clin. Res. 27:321A (1979).
E. A. Chaperon, Suppression of lymphocytes by cephalosporins, in: “The Influence of Antibiotics on the Host-Parasite Relationship,” U. Eickenberg, H. Hahn and W. Opferkuch, eds., Springer-Verlag, Berlin, Heidelberg, New York (1982).
J. Ceuppens and J. S. Goodwin, Endogenous prostaglandin E enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity, Cell. Immunol. 70:41 (1982).
G. J. Damert and P. G. Sohnle, Effect of chloramphenicol on in vitro function of lymphocytes, J. Infect. Pis. 139:220 (1979).
H. U. Eickenberg, H. Hahn and W. Opferkuch, eds., “The Influence of Antibiotics on the Host-Parasite Relationship,” Springer-Verlag, Berlin, Heidelberg, New York (1982).
R. Finch, Immunomodulating effects of antimicrobial agents, J.Antimicrob. Chemother. 6:691 (1980).
A. Forsgren and G. Banck, Influence of antibiotics on lymphocyte function in vitro, Infection 6(Suppl. 1):91 (1978).
H. Friedman, T. W. Klein and A. Szentivanyi, ed., “Immunomodulation by Bacteria and Their Products,” Plenum Press, New York, London (1981).
C. Frugoni and G. Giunchi, Antibiotika und Immunitat bei bakteriellen Infektionen, Scientia medica 3:205 (1954).
D. Gemsa, E. Barlin, H. G. Leser, W. Deimann and M. Seitz, Prostaglandins and leukotrienes: physiological and pathophysiological media-tors of immunity, Behring Inst. Mitt. 68:51 (1981).
G. Gillissen and B. Melzer, L’influence des antibiotiques sur la production de l’interleukine-1 par des macrophages, Path. Biol.\ (in press).
G. Gillissen and Z. Pusztai-Markos, Influence of antibiotics on immunological parameters: significance in experimental infections, Drugs Exptl. Clin. Res. X(11):813 (1984).
G. Gillissen and Z. Pusztai-Markos, Evaluation des effets modulateurs des antibiotiques in vivo sur la phagocytose chez la souris utilisant des methodes differentes, Pathol. Biol. 32:355 (1984).
G. Gillissen, Antibiotika und Immunantwort -Begleiteffekte der Chemotherapie, Immun. Infekt. 8:79 (1980).
G. Gillissen, Nouveaux antibiotiques beta-lactam et response immunitaire, Med. et Hyg. 39:122 (1981).
G. Gillissen, The influence of sodium-8-chlorotheophyllinate (S8CT) on immune processes, Experientia 37:420 (1981).
G. Gillissen, Influence of cephalosporins on humoral immune response, in: “The Influence of Antibiotics on the Host-Parasite relation-ship,” U. Eickenberg, H. Hahn and W. Opferkuch, eds., Springer-Verlag, Berlin, Heidelberg, New York (1982).
G. Gillissen, Interaktion zwischen Antibiotika und Immunabwehr, in: “Infektiologisches Kolloquium 1. Neues von ’alten’ Erregern und neue Erreger,” C. Kraseman, ed., Walter DeGruyter Verlag, Berlin (1983).
G. Gillissen, Influence of cefaclor on immune response parameters, Arzneim.-Forsch./Drug Res. 34:1535 (1984).
G. Gillissen, Possible mechanisms of immunological side-effects of antibiotics, Zbl. Bakt. 13(Suppl.):91 (1985).
J. S. Goodwin, A. D. Bankhurst and R. P. Messner, Suppression of human T cell mitogenesis by prostaglandins, J. Exp. Med. 146:1719 (1977).
J. S. Goodwin and J. Cueppens, Regulation of the immune response by prostaglandins, J. Clin. Immunol. 3:295 (1983).
J. S. Goodwin, P. A. Kaszubowski and R. C. Williams, Jr., Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes, J. Exp. Med. 150:1260 (1979).
J. S. Goodwin, R. P. Messner and G. T. Peake, Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mito-gen dose and preincubation, J. Clin. Invest. 62:753 (1978).
J. S. Goodwin, A. Wiik, M. Lewis, A. D. Bankhurst and R. C. Williams, High affinity binding sites for prostaglandin E on human lympho-cytes, Cell. Immunol. 43:150 (1979).
J. S. Goodwin, Changes in lymphocyte sensitivity to prostaglandin E, histamine, hydrocortisone, and X irradiation with age: studies in a healthy elderly population, Clin. Immunol. Immunopathol. 25:243 (1982).
J. W. Hadden, Cyclic nucleotides in lymphocyte proliferation and diferentiation, in: “Immunopharmacology,” J. W. Hadden, R. G. Coffey and F. Spreafico, eds., Plenum Press, New York (1977).
H. Hahn and S. H. E. Kaufmann, T lymphocyte macrophage interactions in cellular antibacterial immunity, Immunobiol. 161:361 (1982).
W. E. Hauser, Jr. and J. S. Remington, Effect of antibiotics on the immune response, Am. J. Med. 72:711 (1982).
S. H. E. Kaufmann, M. M. Simon and H. Hahn, Regulatory interactions between macrophages and T cell subsets in Listeria monocytogene-specific T cell activation, Infect. Immun. 38:907 (1982).
G. A. Koretzky, J. A. Elias, S. L. Kay, M. D. Rossman, P. C. Nowell and R. P. Daniele, Spontaneous production of interleukin-1 by human alveolar macrophages, Clin. Immunol. Immunopathol. 29:443 (1983).
G. B. Mackaness and R. V. Blanden, Cellular Immunity, Progr. Allergy 11:89 (1967).
L. A. Mandell, Effects of antibiotic, antifungal and antiviral drugs on neutrophil function, in: “Current Chemotherapy and Immuno-therapy, ” P. Periti and G. G. Grassi, eds., The American Soc. for Microbiol., Washington D.C. (1982).
M. Mielke and H. Hahn, Influence of cefsulodin and tetracycline on listeria-specific T cell macrophage interactions in vitro, in: “Proceedings of the 13th Internat. Congr. Chemother. Vienna,” K. H. Spitzy and K. Karrer, eds., H. Egersmann, Vienna (1983).
S. B. Mizel and D. Mizel, Purification to apparent homogenicity of murine interleukin 1, J. Immunol. 126:834 (1981).
S. B. Mizel, J. J. Oppenheim and D. L. Rosenstreich, Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes, J. Immunol. 120:1497 (1978).
S. B. Mizel, D. L. Rosenstreich and J. J. Oppenheim, Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D1, Cell. Immunol. 40:230 (1978).
S. B. Mizel, Studies on the purification and structure-function relationships of murine lymphocyte activating factor (interleukin 1), Mol. Immunol. 17:571 (1980).
M. Mochizuki, J. S. Zigler, P. Russell and I. Gery, Cytostatic and cytolytic activities of macrophages. Regulation by prostaglandins, Cell. Immunol. 83:34 (1984).
T. Morito, A. D. Bankfurst and R. C. Williams, Jr., Studies on the modulation of immunoglobulin production by prostaglandins, Prostaglandins 20:383 (1980).
A. M. Munster, C. B. Loadholdt, A. G. Leary and M. A. Barnes, The effect of antibiotics on cell-mediated immunity, Surgery 81:692 (1977).
R. C. Page, J. A. Clagett, L. D. Engel, G. Wilde and T. Sims, Effects of prostaglandin on the antigen-and mitogen-driven responses of peripheral blood lymphocytes from patients with adult and juvenile periodonitis, Clin. Immunol. Immunopathol. 11:77 (1978).
C. W. Parker, T. J. Sullivan and H. J. Wedner, Cyclic AMP and the immune response, Adv. Cyclic Nucleotide Res. 4:1 (1974).
I. H. Pastan, G. S. Johnson and W. B. Anderson, Role of cyclic nucleotides in growth control, Ann. Rev. Biochem. 44:491 (1975).
M. Plaut and L. M. Lichtenstein, Cellular and chemical basis of the allergic inflammatory response, in: “Allergy, Principles and Practice, Vol. I,” E. Middleton, Jr., C. E. Reed and E. F. Ellis, eds., The C. V. Mosby Co., St. Louis, Toronto (1983).
J. A. Raeburn, Antibiotics and immunodeficiency, Lancet 4:954 (1972).
M. Rollinghoff, Interleukine: ihre Rolle und Wirkung bei der immunologischen Abwehrreaktion, Allergologie 6:397 (1983).
M. Rollinghoff, Interleukine: Signalstoffe des Immunsysterns, Die gelben Hefte XXIII. Jahrgang, 4 (1983).
A. J. Schreurs and F. P. Nijkamp, Contribution of bacterial cell wall compounds to airway hyperreactivity, Int. J. Immunopharmacol. 4:294 (1982).
A. J. M. Schreurs, “Haemophilus Influenzae and the β-Adrenergic System,” University of Utrecht Press, Utrecht, The Netherlands (1982).
K. A. Smith, T cell growth factor, Immunol. Rev. 51:337 (1980).
W. Solbach, M. Rollinghoff and H. Wagner, Die Rolle von Interleukine-2 bei der Aktivierung von zytotoxischen T-Lymphozyten, Klin. Wschr. 61:67 (1983).
D. P. Stites, J. D. Stobo, H. H. Fudenberg and J. V. Wells, eds., “Basic and Clinical Immunology,” Lange Medical Publications, Los Altos (1982).
J. D. Stobo, Cellular interactions in the expression and regulation of immunity, in: “Basic and Clinical Immunology,” D. P. Stites, J. D. Stobo, H. H. Fudenberg and J. V. Wells, eds., Lange Medical Publications, Los Altos (1982).
A. Szentivanyi, E. Middleton, Jr., J. F. Williams and H. Friedman, Effect of microbial agents on the immune network and associated pharmacologic reactivities, in: “Allergy, Principles and Practice, Vol. 1,” E. Middleton, Jr., C. E. Reed and E. F. Ellis, eds., The C. V. Mosby Co., St. Louis, Toronto (1983).
A. Szentivanyi and C. W. Fishel, Effect of bacterial products on responses to the allergic mediators, in: “Immunological Diseases,” M. Samter and H. L. Alexander, eds., Little Brown & Co., Boston (1965).
A. Szentivanyi und C. W. Fishel, Die Amin-Mediatorstoffe der Allergischen Reaktion und die Reaktionsfahigkeit ihrer Exfolgszellen, in: “Pathogenese und Therapie Allergischer Reaktionen: Grundlagenforschung und Klinik,” G. Filipp, ed., Ferdinand Enke Verlag, Stuttgart (1966).
A. Szentivanyi and D. F. Fitzpatrick, The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. II. Effector reactivities in the efferent loop of the immune response, in: “Pathomechanismus und Pathogenese Allergischer Reaktionen,” G. Filipp, ed., Werk-Verlag, Dr. Edmund Banachewski, Grafelfing/Munieh (1980).
H. Wagner, C. Hardt, K. Heeg, K. Pfizenmaier, W. Solbach, R. Bartlett, H. Stockinger and M. Rollinghoff, T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyse CTL responsiveness and thymic maturation of CTL progenitors, Immunolog. Rev. 51:215 (1980).
H. Wagner and M. Rollinghoff, T-T cell interactions during in vitro cytotoxic allograft responses: I. Soluble products from activated Ly 1 T cells trigger autonomously antigen primed Ly 23 T cells to cell proliferation and cytolytic activity, J. Exp. Med. 148:1523 (1978).
D. R. Webb and I. Nowowiejski, Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity, Cell. Immunol. 41:72 (1978).
L. Weinstein and A. C. Dalton, Host determinants of response to antimicrobial agents, N. Engl. J. Med. 279:467, 524, 580 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Gillissen, G. (1987). Attempts to Explain Immunological Side Effects of Antibiotics on the Production of Cellular Mediators. In: Szentivanyi, A., Friedman, H., Gillissen, G. (eds) Antibiosis and Host Immunity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1901-6_30
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1901-6_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9058-2
Online ISBN: 978-1-4613-1901-6
eBook Packages: Springer Book Archive